Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab
2019 · PLoS ONE · 133 citations
https://doi.org/10.1371/journal.pone.0216954
R
Ryoichi Saito
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
195
Papers
2.8K
Citations
27
h-index
55
i10-index
Ryoichi Saito is an academic researcher from Kansai Medical University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Cancer Immunotherapy and Biomarkers & Urinary and Genital Oncology Studies. The author has an h-index of 27, co-authored 166 publications.
ORCID: 0000-0002-3163-8723Papers by this author
worksSystematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies
2019 · British Journal of Cancer · 60 citations
https://doi.org/10.1038/s41416-019-0609-0
Immune‐associated cells in basal cell carcinomas of skin
1996 · Journal of Cutaneous Pathology · 33 citations
https://doi.org/10.1111/j.1600-0560.1996.tb01287.x
A potent chemotherapeutic strategy in prostate cancer: S-(methoxytrityl)-L-cysteine, a novel Eg5 inhibitor
2011 · Asian Journal of Andrology · 20 citations
https://doi.org/10.1038/aja.2010.171
Clinical and molecular correlates of response to immune checkpoint blockade in urothelial carcinoma with liver metastasis
2022 · Cancer Immunology Immunotherapy · 16 citations
https://doi.org/10.1007/s00262-022-03204-6
Hemodynamic Risk Factors for the Development of Carotid Stenosis in Patients with Unilateral Carotid Stenosis
2022 · World Neurosurgery · 14 citations
https://doi.org/10.1016/j.wneu.2022.01.019
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat